31 Aug 2021

Delpharm Overview

PDF 492 kB

Delpharm is a Worldwide leader in contract manufacturing and development of medicines for pharmaceutical laboratories. It owns 17 manufacturing plants (12 in France, 2 in Italy, 1 in Belgium, 1 in the Netherlands and 1 in Canada) providing the majority of dosage forms available on the market: tablets, syrups, bottles, vials, etc. Delpharm generates €800m in turnover and is wholly-owned by its management. For more information, visit our website:

Content provided by our supplier


  • FR
  • 2015
    On CPHI since
  • 4
  • 5000+
Company types
Contract Service

Other Content from Delpharm (1)